Literature DB >> 30848347

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation.

David W Ellison1, Cynthia Hawkins2, David T W Jones3,4, Arzu Onar-Thomas5, Stefan M Pfister3,6, Guido Reifenberger7, David N Louis8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30848347     DOI: 10.1007/s00401-019-01987-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  52 in total

1.  Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.

Authors:  Philip Jonsson; Tejus A Bale; Andrew L Lin; Marc Rosenblum; Ingo K Mellinghoff; Viviane S Tabar; Shahiba Ogilvie; Lauren Schaff; Tzu-I Jonathan Yang; Robert J Young; Barry S Taylor
Journal:  Brain Pathol       Date:  2020-02-12       Impact factor: 6.508

Review 2.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

3.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

4.  Freiburg Neuropathology Case Conference : Hypersalivatory Seizures in a 6-year-old Child.

Authors:  C A Taschner; R Sankowski; C Scheiwe; H Urbach; C Storz; M Prinz
Journal:  Clin Neuroradiol       Date:  2019-09       Impact factor: 3.649

Review 5.  A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm.

Authors:  George S Stoyanov; Lilyana Petkova; Deyan L Dzhenkov
Journal:  Cureus       Date:  2019-12-15

Review 6.  [Challenges and future perspectives in neuro-oncology].

Authors:  Ghazaleh Tabatabai; Michael Weller
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

Review 7.  The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Authors:  Craig Horbinski; Keith L Ligon; Priscilla Brastianos; Jason T Huse; Monica Venere; Susan Chang; Jan Buckner; Timothy Cloughesy; Robert B Jenkins; Caterina Giannini; Roger Stupp; L Burt Nabors; Patrick Y Wen; Kenneth J Aldape; Rimas V Lukas; Evanthia Galanis; Charles G Eberhart; Daniel J Brat; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

8.  Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?

Authors:  Kwok Ling Kam; Christina L Appin; Qinwen Mao; Sachie Ikegami; Rimas V Lukas; Marina N Nikiforova; Somak Roy; Daniel J Brat; Craig Horbinski
Journal:  J Neuropathol Exp Neurol       Date:  2020-07-01       Impact factor: 3.685

9.  Clinical implications of molecular analysis in diffuse glioma stratification.

Authors:  Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Ryusuke Hatae; Yojiro Akagi; Yuhei Sangatsuda; Yutaka Fujioka; Kosuke Takigawa; Yusuke Funakoshi; Satoshi O Suzuki; Toru Iwaki
Journal:  Brain Tumor Pathol       Date:  2021-07-15       Impact factor: 3.298

10.  Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.

Authors:  Jason Chiang; Xiaoyu Li; Anthony P Y Liu; Ibrahim Qaddoumi; Sahaja Acharya; David W Ellison
Journal:  Acta Neuropathol       Date:  2019-12-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.